Trexquant Investment’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,448
Closed -$305K 1892
2023
Q3
$305K Buy
+16,448
New +$186K 0.01% 1216
2023
Q2
Sell
-109,078
Closed -$1.46M 1907
2023
Q1
$1.46M Buy
109,078
+11,077
+11% +$192K 0.04% 575
2022
Q4
$1.21M Sell
98,001
-1,851
-2% -$26.2K 0.03% 583
2022
Q3
$1.39M Buy
99,852
+39,731
+66% +$640K 0.05% 439
2022
Q2
$830K Buy
+60,121
New +$963K 0.04% 600
2021
Q4
Sell
-34,839
Closed -$517K 1727
2021
Q3
$517K Buy
+34,839
New +$557K 0.04% 525
2021
Q2
Sell
-27,004
Closed -$623K 1606
2021
Q1
$623K Buy
+27,004
New +$753K 0.06% 430
2020
Q4
Sell
-17,387
Closed -$721K 1607
2020
Q3
$721K Buy
+17,387
New +$799K 0.05% 534
2020
Q2
Sell
-10,640
Closed -$670K 1564
2020
Q1
$670K Buy
+10,640
New +$956K 0.05% 553
2019
Q4
Sell
-9,227
Closed -$612K 1324
2019
Q3
$612K Sell
9,227
-7,349
-44% -$493K 0.05% 398
2019
Q2
$1.32M Sell
16,576
-8,933
-35% -$800K 0.12% 248
2019
Q1
$2.85M Buy
25,509
+13,450
+112% +$1.47M 0.2% 144
2018
Q4
$1.22M Buy
+12,059
New +$1.25M 0.08% 383
2018
Q2
Sell
-37,238
Closed -$2.29M 1310
2018
Q1
$2.29M Buy
+37,238
New +$2.24M 0.16% 203
2016
Q4
Sell
-6,300
Closed -$1.04M 1181
2016
Q3
$1.04M Buy
+6,300
New +$993K 0.23% 127
2016
Q2
Sell
-8,729
Closed -$1.12M 1166
2016
Q1
$1.12M Buy
+8,729
New +$1.03M 0.13% 261
2015
Q4
Sell
-12,900
Closed -$2.14M 1330
2015
Q3
$2.14M Buy
12,900
+7,600
+143% +$1.67M 0.18% 137
2015
Q2
$1.28M Buy
+5,300
New +$1.41M 0.14% 247
2015
Q1
Sell
-8,800
Closed -$1.37M 1242
2014
Q4
$1.37M Buy
+8,800
New +$1.63M 0.24% 65

Trexquant Investment's ICPT Position: Q4 2023 in Review

Trexquant Investment sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 16,448 shares — an estimated $305K sold.

Trexquant Investment first reported a position in ICPT in Q4 2014 and held it in 19 quarters. The position peaked at $2.85M in Q1 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Trexquant Investment reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 16,448 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $305K.
  • Trexquant Investment first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 19 quarters.
  • Trexquant Investment's Intercept Pharmaceuticals, Inc. position peaked at $2.85M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.